CLINICAL_TRIALS
trial_result
· 2022-04-08
Clinical Trial Update: Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer [Phase 1]
Summary
Phase 1 trial evaluating mFOLFOX6 with selinexor in metastatic colorectal cancer has been terminated; results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GSO Global Clinical Research BV | Conditions: Colorectal Neoplasm | Phase 1 | Status: TERMINATED | Results posted: 2022-04-08